Skip to main content
. Author manuscript; available in PMC: 2014 Aug 28.
Published in final edited form as: J Control Release. 2013 May 3;170(1):51–63. doi: 10.1016/j.jconrel.2013.04.021

Table 2.

IMQ-induced skin inflammation in mice phenotypically resembles psoriasis. C57BL/6 mice were treated daily for 5 days with IMQ suspension on the shaved back skin and then the inflamed area was treated with CyLiPn formulations (C-CyLiPn, S-CyLiPn and CS-CyLiPn); CS-Solution; and Topgraf®. Psoriasis Area and Severity Index (PASI) score of the back skin was recorded daily on a scale from 0 to 4. Data represent mean ± SD (n=6).

Day Normal IMQ S-CyLiPn C-CyLiPn CS-CyLiPn Topgraf® C-Solution
1 0 ± 0 4 ± 0 4 ± 0 4 ± 0 4 ± 0 4 ± 0 4 ± 0
2 0 ± 0 4 ± 0 3 ± 0.55 3 ± 0.51 2 ± 0.55 1 ± 0.51 3 ± 0.41
3 0 ± 0 4 ± 0 2 ± 0.52 3 ± 0.41 2 ± 0.41 1 ± 0.41 3 ± 0.51
4 0 ± 0 4 ± 0 2 ± 0.52 3 ± 0.41 1 ± 0.51 0 ± 0.51 3 ± 0.51
5 0 ± 0 4 ± 0 2 ± 0.41 2 ± 0.55 0 ± 0.41 0 ± 0.41 3 ± 0.55